Litcius/Paper detail

Case report: A kidney transplant patient with mild COVID‐19

Emre Arpalı, Başak Akyollu, Berna Yelken, Süda Tekin, Aydın Türkmen, Burak Koçak

2020Transplant Infectious Disease59 citationsDOIOpen Access PDF

Abstract

Coronavirus Disease 2019 (COVID-19) is currently a pandemic with a mortality rate of 1%-6% in the general population. However, the mortality rate seems to be significantly higher in elderly patients, especially those hospitalized with comorbidities, such as hypertension, diabetes, or coronary artery diseases. Because viral diseases may have atypical presentations in immunosuppressed patients, the course of the disease in the transplant patient population is unknown. Hence, the management of these patients with COVID-19 is an area of interest, and a unique approach is warranted. Here, we report the clinical features and our treatment approach for a kidney transplant patient with a diagnosis of COVID-19. We believe that screening protocols for SARS-Cov-2 should be re-evaluated in patients with solid-organ transplants.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)PopulationPandemicDiabetes mellitusCoronary artery diseaseIntensive care medicineMortality rateDiseaseKidney transplantationKidney transplantKidney diseaseInternal medicineKidneyInfectious disease (medical specialty)EndocrinologyEnvironmental healthCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research